Cel Sci Corp. (CVM) intrinsic value & 10-year financials
Cel Sci Corp. (CVM) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $1.79
- Market cap
- $7.3M
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- 260.4%
- Free cash flow (FY2025)
- -$17.2M
CVM 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$25.4M | -$6.27 | -$17.2M | — | -180.2% |
| FY2024 | — | -$27.6M | -$0.51 | -$18.9M | — | -144.5% |
| FY2023 | — | -$32.2M | -$0.73 | -$23.2M | — | -147.2% |
| FY2022 | — | -$36.7M | -$0.87 | -$18.9M | — | -124.8% |
| FY2021 | — | -$36.4M | -$0.93 | -$27.8M | — | -137.6% |
| FY2020 | — | -$30.3M | -$0.82 | -$17.9M | — | -221.8% |
| FY2019 | — | -$22.1M | -$0.71 | -$16.5M | — | -217.1% |
| FY2018 | — | -$31.8M | -$1.87 | -$13.4M | — | 1908.7% |
| FY2017 | — | -$14.4M | -$1.91 | -$13.8M | — | 669.1% |
| FY2016 | — | -$11.5M | -$0.09 | -$23.1M | — | 1199.3% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
CEL SCI CORP revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
CEL SCI CORP has historically struggled to out-earn its cost of capital, averaging just -52.3% ROIC.
Over the decade, CEL SCI CORP shows that management has aggressively returned capital to shareholders by retiring 96.7% of outstanding shares.
Benjamin Graham lens
CEL SCI CORP is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.